Advertisement
U.S. markets closed
Advertisement

CVS Health Corporation (CVS)

NYSE - Nasdaq Real Time Price. Currency in USD
75.10+1.09 (+1.47%)
At close: 04:00PM EST
75.11 +0.01 (+0.01%)
After hours: 07:59PM EST
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 12/10/2023
Current
9/30/20236/30/20233/31/202312/31/20229/30/2022
Market Cap (intraday)
96.65B89.68B88.62B95.04B122.45B125.41B
Enterprise Value
160.55B154.93B143.63B150.05B173.53B184.59B
Trailing P/E
11.5031.8822.9723.6739.3215.53
Forward P/E
8.808.128.048.4310.5410.58
PEG Ratio (5 yr expected)
0.340.311.361.261.261.29
Price/Sales (ttm)
0.280.270.270.300.390.41
Price/Book (mrq)
1.301.241.241.341.711.67
Enterprise Value/Revenue
0.461.731.621.762.072.27
Enterprise Value/EBITDA
8.8132.0232.9433.5847.40-65.13

Trading Information

Stock Price History

Beta (5Y Monthly) 0.53
52-Week Change 3-27.64%
S&P500 52-Week Change 315.38%
52 Week High 3104.83
52 Week Low 364.41
50-Day Moving Average 369.61
200-Day Moving Average 371.51

Share Statistics

Avg Vol (3 month) 37.71M
Avg Vol (10 day) 310.03M
Shares Outstanding 51.29B
Implied Shares Outstanding 61.29B
Float 81.28B
% Held by Insiders 10.14%
% Held by Institutions 180.04%
Shares Short (Nov 14, 2023) 415.84M
Short Ratio (Nov 14, 2023) 42.15
Short % of Float (Nov 14, 2023) 41.23%
Short % of Shares Outstanding (Nov 14, 2023) 41.23%
Shares Short (prior month Oct 12, 2023) 413.82M

Dividends & Splits

Forward Annual Dividend Rate 42.66
Forward Annual Dividend Yield 43.54%
Trailing Annual Dividend Rate 32.37
Trailing Annual Dividend Yield 33.20%
5 Year Average Dividend Yield 42.87
Payout Ratio 436.22%
Dividend Date 3Jan 31, 2024
Ex-Dividend Date 4Jan 18, 2024
Last Split Factor 22:1
Last Split Date 3Jun 06, 2005

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Sep 29, 2023

Profitability

Profit Margin 2.44%
Operating Margin (ttm)3.93%

Management Effectiveness

Return on Assets (ttm)3.64%
Return on Equity (ttm)11.67%

Income Statement

Revenue (ttm)346.6B
Revenue Per Share (ttm)268.63
Quarterly Revenue Growth (yoy)10.50%
Gross Profit (ttm)53.46B
EBITDA 18.34B
Net Income Avi to Common (ttm)8.47B
Diluted EPS (ttm)6.53
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)16.19B
Total Cash Per Share (mrq)12.58
Total Debt (mrq)80.1B
Total Debt/Equity (mrq)107.50%
Current Ratio (mrq)0.86
Book Value Per Share (mrq)57.76

Cash Flow Statement

Operating Cash Flow (ttm)14.11B
Levered Free Cash Flow (ttm)11.98B